Here, we found that COPB2 was significantly up‐regulated in a large cohort of human breast cancer tissues and that COPB2 levels significantly linked with the clinical characteristics of BC, including oestrogen receptor (ER) and BC lymph node metastasis. Here, COPB2 is linked to breast cancer.